|The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes|
HH Parving, H Lehnert, J Bröchner-Mortensen, R Gomis, S Andersen, ...
New England Journal of Medicine 345 (12), 870-878, 2001
|Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC|
LM Mulligan, C Eng, CS Healey, D Clayton, JBJ Kwok, E Gardner, ...
Nature genetics 6 (1), 70-74, 1994
|Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients|
R Lobmann, A Ambrosch, G Schultz, K Waldmann, S Schiweck, H Lehnert
Diabetologia 45 (7), 1011-1016, 2002
|The predictive value of different measures of obesity for incident cardiovascular events and mortality|
HJ Schneider, N Friedrich, J Klotsche, L Pieper, M Nauck, U John, M Dorr, ...
The Journal of Clinical Endocrinology & Metabolism 95 (4), 1777-1785, 2010
|The theory of constructed emotion: an active inference account of interoception and categorization|
Social cognitive and affective neuroscience 12 (1), 1-23, 2017
|Malignant pheochromocytoma: current status and initiatives for future progress|
G Eisenhofer, SR Bornstein, FM Brouwers, NKV Cheung, PL Dahia, ...
Endocrine-related cancer 11 (3), 423-436, 2004
|Accuracy of anthropometric indicators of obesity to predict cardiovascular risk|
HJ Schneider, H Glaesmer, J Klotsche, S Bohler, H Lehnert, AM Zeiher, ...
The Journal of Clinical Endocrinology & Metabolism 92 (2), 589-594, 2007
|Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose|
BK Tan, R Adya, S Farhatullah, KC Lewandowski, P O’Hare, H Lehnert, ...
Diabetes 57 (4), 801-808, 2008
|Short-term sleep loss decreases physical activity under free-living conditions but does not increase food intake under time-deprived laboratory conditions in healthy men|
SM Schmid, M Hallschmid, K Jauch-Chara, B Wilms, C Benedict, ...
The American journal of clinical nutrition 90 (6), 1476-1482, 2009
|Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled|
P Bramlage, D Pittrow, HU Wittchen, W Kirch, S Boehler, H Lehnert, ...
American journal of hypertension 17 (10), 904-910, 2004
|Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity|
M Ramanjaneya, J Chen, JE Brown, G Tripathi, M Hallschmid, S Patel, ...
Endocrinology 151 (7), 3169-3180, 2010
|Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104: H4 induced haemolytic uraemic syndrome: case-control study|
J Menne, M Nitschke, R Stingele, M Abu-Tair, J Beneke, J Bramstedt, ...
Bmj 345, e4565, 2012
|Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes|
N Engl J Med 345, 870-878, 2001
|Interaction of tumor cells with the microenvironment|
H Ungefroren, S Sebens, D Seidl, H Lehnert, R Hass
Cell Communication and Signaling 9 (1), 18, 2011
|Cardiometabolic aspects of the polycystic ovary syndrome|
HS Randeva, BK Tan, MO Weickert, K Lois, JE Nestler, N Sattar, ...
Endocrine reviews 33 (5), 812-841, 2012
|Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications|
R Lobmann, G Schultz, H Lehnert
Diabetes care 28 (2), 461-471, 2005
|Insulin and metformin regulate circulating and adipose tissue chemerin|
BK Tan, J Chen, S Farhatullah, R Adya, J Kaur, D Heutling, ...
Diabetes 58 (9), 1971-1977, 2009
|Neurochemical and behavioral consequences of acute, uncontrollable stress: effects of dietary tyrosine|
H Lehnert, DK Reinstein, BW Strowbridge, RJ Wurtman
Brain research 303 (2), 215-223, 1984
|Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance|
BK Tan, D Heutling, J Chen, S Farhatullah, R Adya, SD Keay, ...
Diabetes 57 (6), 1501-1507, 2008
|Current treatment of malignant pheochromocytoma|
T Scholz, G Eisenhofer, K Pacak, H Dralle, H Lehnert
The Journal of Clinical Endocrinology & Metabolism 92 (4), 1217-1225, 2007